Skip to NavigationSkip to content

News

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the...
Janssen’s ulcerative colitis treatment, Stelara (ustekinumab subcutaneous) has shown positive results as maintenance therapy in phase 3 trials.
Eli Lilly’s Cyramza has succeeded in hitting its primary endpoint at Phase 3 in combination with erlotinib, the company said, as a first-line...
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to pharmaceutical industry...
The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply after recalls were made in...
Dupixent has been authorised by the FDA to expand its approved indications to include the treatment of moderate-to-severe atopic dermatitis in...
Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales of its generic version of...
Britain’s cost effectiveness body NICE have recommended Janssen Pharmaceutical’s Darzalex in combination with Velcade and dexamethasone (DVd), for...
Patients in the US will now be able to access another biosimilar version of Herceptin (trastuzumab) with the FDA approval of Pfizer’s Trazimera in...
Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches